Summary: India-based pharmaceutical company Hetero Drugs prepared the first batch of made in India Remdesivir, a COVID-19 drug. 20,000 vials of the COVID drug have been sent to the five worst-hit states. Treatment needs 6 doses each priced at Rs 5,400. India's top doctors discuss if this is the beginning of the end of the coronavirus crisis.
